Thread by @Health_Affairs

BREAKING: Promoting Effectiveness And Equity As COVID-19 Vaccines And Treatment Emerge.
Today, we focus on #COVID19 #vaccines & treatment. Amidst recent news of successful vaccine trials & new treatments, we highlight key policy + regulatory issues: bit.ly/2UJBxlg (1/9)

This set of fast-track ahead-of-print journal articles kicks off with @AKesselheim of @BrighamWomens et al's paper, which explores #vaccine development, approval, and regulation as well as tradeoffs in balancing safety, efficacy, and speed: bit.ly/3pJySGM (2/9)

How successful will new #vaccines be? While more effective vaccines always lead to better outcomes, the story gets complex when you start to vary the parameters. @jasonlschwartz & @ADPaltiel from @YaleSPH w/ coauthors from @harvardmed investigate: bit.ly/33gugyj

Three analytic papers review key policy questions such as why we must invest in #vaccine delivery strategies; how public and private leaders can ensure equitable access; and what to consider in pricing vaccines and #treatments. #COVID19

#DeliveryStrategies: Rebecca Weintraub et al. of @AriadneLabs analyze why leaders must invest in vaccine delivery strategies now. They offer recommendations for policymakers and look at past #pandemics and #vaccine campaigns to offer lessons: bit.ly/330Ww7H

#Equity: @AngelaKShen of @ChildrensPhila and coauthors offer recommendations to leaders to help ensure equitable access to all who are recommended for #vaccination, regardless of finances, location, or historic/systemic limitations to health care: bit.ly/3952qIG

#DrugPricing: @PeterNeumann11 et al. of @TuftsMedicalCtr explain solutions to the "policy puzzle" of balancing lower prices to ensure access to tests + vaccines, while ensuring revenue to provide manufacturers incentives to make key investments: bit.ly/3kHwCvX

In preparation for publishing these peer-reviewed papers today, Health Affairs brought researchers, industry leaders, and advocates together at an August 2020 symposium (watch here: bit.ly/3pKxvav) to discuss promoting #vaccine and treatment #innovation and equity.

Reporter @Meyer_HM summarized the event in this month’s EntryPoint in Health Affairs, noting themes of collaboration and competition: bit.ly/2KpnnEb

Stay up-to-date with continuing special coverage on #vaccines and treatment relating to the #COVID19 #pandemic here: bit.ly/2UJBxlg

A huge thank you to our funders @AnthemInc; @Amgen; @avalerehealth; @aboutKP; @PhRMA; @GileadSciences; @McKesson; @QuestDX; @DynavaxCorp; @AlexionPharma; and @Danaher_U.